Drug Discovery News
Most Popular Drug Discovery Story
Boehringer anti-clotting drug performs in Phase III
The race for a new anti-clotting therapy turned even hotter today as Boehringer Ingelheim announced that a late-stage study of its once daily pill dabigatran showed that the therapy is as effective Read more...
Latest Headlines
- July 25, 2007
- July 19, 2007
- July 19, 2007
- July 18, 2007
- July 17, 2007
- July 16, 2007
- July 16, 2007
- July 16, 2007
- July 13, 2007
- July 13, 2007
- July 12, 2007
- July 11, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
